Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06027515 · ClinicalTrials.gov registry record · NA

Esophageal Cancer Multimodal Prehabilitation Study

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT06027515: Completed NA study, sponsored by Massachusetts General Hospital.

NCT06027515 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06027515, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.

Interventions

  • BEHAVIORAL Prehabilitation Program

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2023-12-01
Est. Completion 2026-01-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06027515

The ClinicalTrials.gov registry entry for NCT06027515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Prehabilitation Program is the first listed.

NCT06027515 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06027515 about?

NCT06027515 is a clinical study titled "Esophageal Cancer Multimodal Prehabilitation Study". The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.

What is the current status of trial NCT06027515?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-12-01. Estimated completion is 2026-01-31.

What interventions are being tested in trial NCT06027515?

The interventions under investigation include: Prehabilitation Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06027515?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.